TABLE 3

Cytochrome P450 inhibition by common ABC transporter inhibitor in human microsomes and cryopreserved hepatocytes.

InhibitorInhibition of Loperamide MetabolismInhibition of Midazolam Metabolism
Liver MicrosomesCryopreserved HepatocytesFold Difference
(mic/hep)Liver MicrosomesCryopreserved HepatocytesFold Difference
(mic/hep)
IC50 (μM)IC50 (μM)
Cyclosporin A15.3 ± 1.226.3 ± 1.60.667.8 ± 2.565.8 ± 1.41.0
Elacridar17.8 ± 1.462.0 ± 1.6*0.331.7 ± 1.5400.5 ± 2.5**0.08
Ketoconazole0.4 ± 0.21.0 ± 0.3*0.40.3 ± 0.40.9 ± 1.10.3
Quinidine116.4 ± 2.64.8 ± 1.3**24.3263.2 ± 5.228.3 ± 2.1**9.3
Reserpine1.0 ± 1.57.2 ± 1.4*0.1121.8 ± 1.6266.2 ± 2.80.5
Tacrolimus6.3 ± 1.310.7 ± 1.50.69.0 ± 1.218.1 ± 1.80.5
Measured BindingaCalculated Bindingb
fumicS.D.fuhepS.D.Ratio (mic/hep)fumicfuhepRatio (mic/hep)
Cyclosporin A0.020.010.020.011.10.320.271.2
Elacridar0.0050.0020.01**0.010.40.280.241.2
Ketoconazole0.330.060.470.090.70.840.811.0
Quinidine0.830.050.910.020.90.810.771.0
Reserpine0.170.020.190.020.90.500.451.1
Tacrolimus0.170.020.180.030.90.840.811.0
Midazolam0.300.020.360.040.80.160.131.2
Loperamide0.740.010.800.010.90.540.481.1
  • Mean ± S.E. listed, n = 3, for elacridar n = 4. The experiment was performed on three separate occasions. IC50 values are based on total concentration. * P < 0.05, ** P < 0.01, statistically significant difference between values in cryopreserved hepatocytes and microsomes.

  • Hep, cryopreserved hepatocyte; Mic, microsome.

  • a The fuinc in microsome and hepatocyte incubations was measured according to Mateus et al., 2013.

  • b The fuinc in microsome and hepatocyte incubations was calculated according to eq. 1 and eq. 2.